@article{038246e04cad403f904d5fcf893e1aca,
title = "Serial 89Zr-bevacizumab PET in Patients with Neuroendocrine Tumors before and on Everolimus Treatment",
keywords = "neuroendocrine tumors, 89zr-bevacizumab pet, vegf-a, everolimus, biomarker",
author = "Brouwers, {A. H.} and {Van Asselt}, {S. J.} and Oosting, {S. F.} and {De Jong}, {J. R.} and {Lub-de Hooge}, {M. N.} and Bongaerts, {A. H. H.} and {Oude Munnink}, Thijs and Fiebrich, {H. B.} and Sluiter, {W. J.} and Links, {T. P.} and Walenkamp, {A. M. E.} and {de Vries}, Liesbeth",
year = "2014",
language = "English",
volume = "99",
pages = "259",
journal = "Neuroendocrinology",
issn = "0028-3835",
publisher = "KARGER",
number = "3-4",
note = "11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease ; Conference date: 05-03-2014 Through 07-03-2014",
}